Crosstalk between ERO1α and ryanodine receptor in arsenite-dependent mitochondrial ROS formation.
Arsenite
ERO1α
Inositol-1,4,5-triphosphate receptor
Mitochondrial Ca(2+)
Mitochondrial superoxide
Ryanodine receptor
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
13
12
2021
revised:
14
02
2022
accepted:
15
02
2022
pubmed:
22
2
2022
medline:
26
4
2022
entrez:
21
2
2022
Statut:
ppublish
Résumé
Arsenite, a well-established human carcinogen and toxic compound, promotes the formation of mitochondrial superoxide (mitoO
Identifiants
pubmed: 35189109
pii: S0006-2952(22)00067-3
doi: 10.1016/j.bcp.2022.114973
pii:
doi:
Substances chimiques
Arsenites
0
Membrane Glycoproteins
0
RYR1 protein, human
0
Reactive Oxygen Species
0
Ryanodine Receptor Calcium Release Channel
0
ERO1A protein, human
EC 1.-
Oxidoreductases
EC 1.-
arsenite
N5509X556J
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114973Informations de copyright
Copyright © 2022. Published by Elsevier Inc.